[PHARMA] YoY TTM Result on 30-Jun-2007 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2007
Quarter
30-Jun-2007 [#2]
Profit Trend
QoQ- 7.46%
YoY- -24.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Revenue 1,321,763 1,289,459 1,290,632 1,112,447 967,662 900,698 692,766 11.36%
PBT 69,675 86,658 103,949 32,429 26,688 77,406 72,514 -0.66%
Tax -17,335 -24,472 -33,502 -16,635 -6,615 -30,064 -28,527 -7.96%
NP 52,340 62,186 70,447 15,794 20,073 47,342 43,987 2.93%
-
NP to SH 52,027 60,598 69,023 14,068 18,614 46,979 43,987 2.83%
-
Tax Rate 24.88% 28.24% 32.23% 51.30% 24.79% 38.84% 39.34% -
Total Cost 1,269,423 1,227,273 1,220,185 1,096,653 947,589 853,356 648,779 11.83%
-
Net Worth 417,065 400,161 362,716 314,357 316,871 256,928 240,475 9.60%
Dividend
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Div 118,755 57,770 38,516 16,038 15,951 15,333 22,592 31.84%
Div Payout % 228.26% 95.33% 55.80% 114.01% 85.70% 32.64% 51.36% -
Equity
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Net Worth 417,065 400,161 362,716 314,357 316,871 256,928 240,475 9.60%
NOSH 106,939 106,995 106,995 106,924 107,051 102,361 101,039 0.94%
Ratio Analysis
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
NP Margin 3.96% 4.82% 5.46% 1.42% 2.07% 5.26% 6.35% -
ROE 12.47% 15.14% 19.03% 4.48% 5.87% 18.28% 18.29% -
Per Share
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
RPS 1,235.99 1,205.16 1,206.24 1,040.41 903.93 879.92 685.64 10.31%
EPS 48.65 56.64 64.51 13.16 17.39 45.89 43.53 1.86%
DPS 111.00 54.00 36.00 15.00 14.90 15.00 22.50 30.45%
NAPS 3.90 3.74 3.39 2.94 2.96 2.51 2.38 8.57%
Adjusted Per Share Value based on latest NOSH - 106,924
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
RPS 91.71 89.47 89.55 77.19 67.14 62.50 48.07 11.36%
EPS 3.61 4.20 4.79 0.98 1.29 3.26 3.05 2.84%
DPS 8.24 4.01 2.67 1.11 1.11 1.06 1.57 31.81%
NAPS 0.2894 0.2777 0.2517 0.2181 0.2199 0.1783 0.1669 9.60%
Price Multiplier on Financial Quarter End Date
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Date 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 30/06/05 30/06/04 -
Price 4.98 3.80 3.27 3.53 4.51 4.53 4.82 -
P/RPS 0.40 0.32 0.27 0.34 0.50 0.51 0.70 -8.90%
P/EPS 10.24 6.71 5.07 26.83 25.94 9.87 11.07 -1.28%
EY 9.77 14.90 19.73 3.73 3.86 10.13 9.03 1.32%
DY 22.29 14.21 11.01 4.25 3.30 3.31 4.67 29.74%
P/NAPS 1.28 1.02 0.96 1.20 1.52 1.80 2.03 -7.39%
Price Multiplier on Announcement Date
30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 CAGR
Date 11/08/10 21/08/09 14/08/08 17/08/07 16/08/06 18/08/05 06/08/04 -
Price 4.95 4.00 3.44 3.44 4.00 5.00 4.64 -
P/RPS 0.40 0.33 0.29 0.33 0.44 0.57 0.68 -8.46%
P/EPS 10.17 7.06 5.33 26.15 23.00 10.89 10.66 -0.78%
EY 9.83 14.16 18.75 3.82 4.35 9.18 9.38 0.78%
DY 22.42 13.50 10.47 4.36 3.73 3.00 4.85 29.05%
P/NAPS 1.27 1.07 1.01 1.17 1.35 1.99 1.95 -6.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment